Tag: Sanofi India Q4 results

Sanofi India Q4 revenue, EBITDA rise; ₹117 final dividend recommended – CNBC TV18

[ad_1] Sanofi India Ltd. (SIL) posted steady growth in the fourth quarter of 2024, with revenue increasing by 9.7% year-on-year (YoY) to ₹514.9 crore, compared to ₹469.2 crore in the corresponding quarter of the previous year. EBITDA rose 18.8% YoY to ₹118.3 crore, up from ₹99.6 crore. Operating margins also improved to 23%, compared to […]

Back To Top
Translate »